Live Markets News

Loading market data...

markets

CERo completes second cohort dosing in phase 1 trial

Investing.comMay 11, 2026 at 12:24 PMPaywall

Read Full Article at Investing.com →

Share:Post Share

CERo completes second cohort dosing in phase 1 trial

CERo completes second cohort dosing in phase 1 trial

This is a summary. For the full story, read the original article at Investing.com.

Original source: Investing.com

Related Articles

Inhibrx reports interim phase 2 data for cancer drug trial

Investing.comMay 11, 2026 at 12:25 PM

The investor who backed Nvidia in 2016 and a memory-chip maker in 2024 now has a third conviction call

MarketWatchMay 11, 2026 at 9:13 AM

‘I nearly made a major misstep’: I claimed my Social Security benefits at 64 instead of 70. Here’s why.

MarketWatchMay 11, 2026 at 9:15 AM

← Back to all articles